OBLN Obalon Therapeutics, Inc. Stock Quote

OBLN [NASD]

Index	-	P/E	-	EPS (ttm)	-2.06	Insider Own	-	Shs Outstand	7.73M	Perf Week	-16.78%
Market Cap	30.41M	Forward P/E	-	EPS next Y	-0.27	Insider Trans	-	Shs Float	7.47M	Perf Month	-19.73%
Income	-15.90M	PEG	-	EPS next Q	-0.06	Inst Own	39.60%	Short Float	5.93%	Perf Quarter	326.23%
Sales	2.30M	P/S	13.22	EPS this Y	74.40%	Inst Trans	-0.24%	Short Ratio	0.03	Perf Half Y	311.27%
Book/sh	0.77	P/B	4.70	EPS next Y	-	ROA	-97.30%	Target Price	-	Perf Year	158.57%
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-159.10%	52W Range	0.62 - 10.77	Perf YTD	141.33%
Dividend	-	P/FCF	-	EPS past 5Y	4.10%	ROI	-147.00%	52W High	-66.39%	Beta	-1.18
Dividend %	-	Quick Ratio	1.80	Sales past 5Y	-1.50%	Gross Margin	29.50%	52W Low	483.87%	ATR	0.85
Employees	34	Current Ratio	1.80	Sales Q/Q	-	Oper. Margin	-	RSI (14)	45.67	Volatility	11.20% 12.32%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	67.00%	Profit Margin	-	Rel Volume	0.01	Prev Close	3.43
Shortable	Yes	LT Debt/Eq	0.07	Earnings	-	Payout	-	Avg Volume	14.04M	Price	3.62
Recom	2.00	SMA20	-16.88%	SMA50	11.36%	SMA200	143.91%	Volume	180,179	Change	5.54%

Feb-25-19

Upgrade

Stifel

Hold → Buy

$2.50 → $3

Aug-03-18

Reiterated

Stifel

Hold

$3 → $2

Mar-01-21 05:03PM	SHAREHOLDER ALERT: WeissLaw LLP Reminds IPHI, OBLN, IACA, and TPGY Shareholders About Its Ongoing Investigations PR Newswire +5.54%
Feb-14-21 01:30PM	Lifshitz Law Firm, P.C. Announces Investigation of CHNG, MGLN, OBLN, and OXFD ACCESSWIRE
Feb-10-21 12:02AM	INVESTIGATION ALERT: Halper Sadeh LLP Investigates CUB, CRHM, GLUU, OXFD, OBLN; Shareholders Are Encouraged to Contact the Firm PR Newswire +10.28%
Feb-07-21 08:01AM	Lifshitz Law Firm, P.C. Announces Investigation of CHNG, CPAH, HMSY, INFO, MGLN, NAV, OBLN, OXFD, and WTRE PR Newswire
Feb-02-21 10:37AM	INVESTIGATION ALERT: Halper Sadeh LLP Investigates VIE, SMTX, NK, OBLN; Shareholders Are Encouraged to Contact the Firm GlobeNewswire -8.59%
Jan-28-21 05:47PM	SHAREHOLDER ALERT: WeissLaw LLP Reminds OBLN, HEC, CNIG and CHNG Shareholders About Its Ongoing Investigations PR Newswire -11.05%
Jan-25-21 01:19PM	SHAREHOLDER ALERT: Halper Sadeh LLP Investigates OBLN, CIT, ZAGG, HLIX; Shareholders Are Encouraged to Contact the Firm GlobeNewswire -7.97%
11:30AM	SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Obalon Therapeutics, Inc. Merger GlobeNewswire
Jan-24-21 11:07AM	Lifshitz Law Firm, P.C. Announces Investigation of CHNG, COHR, LITE, CPAH, MGLN, NAV, OBLN, OXFD and WTRE PR Newswire
Jan-23-21 08:13AM	SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Obalon Therapeutics, Inc. - OBLN PR Newswire
Jan-22-21 04:46PM	OBALON ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of OBLN and Encourages Investors to Contact the Firm GlobeNewswire +15.99%
11:44AM	ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - CHNG, OXFD, SMTX, OBLN, ALXN, BYFC, CIT PR Newswire
11:30AM	OBALON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Obalon Therapeutics, Inc. - OBLN Business Wire
Jan-21-21 02:57PM	SHAREHOLDER ALERT: WeissLaw LLP Investigates Obalon Therapeutics, Inc. PR Newswire -37.32%
10:00AM	ROCE Insights For Obalon Therapeutics Benzinga
Jan-20-21 02:54PM	Obalon Therapeutics stock soars to lead all gainers on massive volume after ReShape merger deal MarketWatch +414.29%
Dec-07-20 10:33AM	Why Is It Moving? Analyzing The Upward Movement in Obalon Therapeutics's Stock Today Benzinga +114.95%
09:42AM	Return On Capital Employed Overview: Obalon Therapeutics Benzinga
Nov-26-20 08:14PM	Is Obalon Therapeutics, Inc. (OBLN) A Good Stock To Buy? Insider Monkey
Nov-06-20 04:45PM	Obalon Announces Third Quarter 2020 Financial Results GlobeNewswire
Aug-13-20 07:00AM	Obalon Announces Consulting Agreement As Part of Strategy To Seek Coverage and Reimbursement for The Obalon Balloon System GlobeNewswire +7.39%
Jul-30-20 06:38AM	Obalon Announces Second Quarter 2020 Financial Results GlobeNewswire
Jun-19-20 06:15AM	Obalon Announces First Quarter 2020 Financial Results and Business Update GlobeNewswire -28.04%
May-11-20 08:30AM	Obalon Announces Further Impacts Related To Covid-19 Crisis and Current Business Environment GlobeNewswire -12.43%
May-08-20 08:00AM	William Plovanic Resigns as President and Chief Executive Officer and Will Continue to Serve Solely as Director GlobeNewswire
Apr-28-20 09:00AM	Obalon Gas-Filled Balloon Not Subject of Fourth FDA Letter to Health Care Providers Related To Serious Risks, Including Death, With Liquid-Filled Intragastric Balloons GlobeNewswire
Mar-25-20 08:44AM	Obalon Therapeutics explores strategic alternatives as coronavirus hits Reuters
08:30AM	Obalon Engages Canaccord Genuity to Explore Financial and Strategic Alternatives GlobeNewswire
Mar-18-20 07:36AM	The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates Benzinga -15.28%
Mar-17-20 05:21PM	Obalon Temporarily Suspends New Patient Sales at Its Retail Treatment Centers Due to Coronavirus Pandemic GlobeNewswire
Mar-12-20 01:48PM	Edited Transcript of OBLN earnings conference call or presentation 27-Feb-20 1:30pm GMT Thomson Reuters StreetEvents -18.41%
Feb-27-20 07:31AM	Obalon Announces Fourth Quarter and Full Year 2019 Financial Results GlobeNewswire -23.60%
Feb-20-20 08:15AM	Obalon Announces Opening of Second Retail Treatment Center in Orange County, CA GlobeNewswire
Feb-13-20 09:00AM	Obalon Schedules Fourth Quarter and Year-End 2019 Financial Results Conference Call for February 27, 2020 at 8:30 a.m. Eastern Time GlobeNewswire
Feb-07-20 04:15PM	Obalon Enters into New Stock Purchase Agreement with Lincoln Park Capital Fund GlobeNewswire
Jan-24-20 11:30AM	Is OBALON THERPTCS (OBLN) Stock Outpacing Its Medical Peers This Year? Zacks
Jan-13-20 01:27PM	Have Insiders Been Buying Obalon Therapeutics, Inc. (NASDAQ:OBLN) Shares? Simply Wall St.
Dec-18-19 08:30AM	Obalon Enters into a Distribution Agreement for Qatar GlobeNewswire
Dec-10-19 01:27PM	Spindletop Capital Management Promotes Kelly Huang, Ph.D. to Managing Director PR Newswire
Nov-27-19 12:10AM	Edited Transcript of OBLN earnings conference call or presentation 8-Nov-19 2:00pm GMT Thomson Reuters StreetEvents
Nov-14-19 09:00AM	Obalon To Present at Two Upcoming Institutional Investor Conferences GlobeNewswire
Nov-13-19 09:43AM	Could Obalon Therapeutics, Inc.'s (NASDAQ:OBLN) Investor Composition Influence The Stock Price? Simply Wall St.
Nov-08-19 08:25AM	OBALON THERPTCS (OBLN) Reports Q3 Loss, Misses Revenue Estimates Zacks -6.15%
08:14AM	The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut Benzinga
07:15AM	Obalon Announces Third Quarter 2019 Financial Results GlobeNewswire
Nov-05-19 05:15AM	Obalon Announces Clinical Data Set to be Featured During the 36th ASMBS Annual Meeting at Obesity Week 2019 GlobeNewswire +6.08%
Nov-01-19 10:30AM	OBALON THERPTCS (OBLN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Oct-31-19 07:15AM	Obalon Schedules Third Quarter 2019 Financial Results Conference Call for November 8, 2019 at 9:00 a.m. Eastern Time GlobeNewswire
Oct-25-19 10:30AM	Will OBALON THERPTCS (OBLN) Report Negative Q3 Earnings? What You Should Know Zacks
Oct-24-19 08:15AM	Obalon Appoints William J. Plovanic as Chief Executive Officer and Nooshin Hussainy as Chief Financial Officer GlobeNewswire
Oct-22-19 08:15AM	Obalon Announces First Patient Treatments at its First Company-Owned Center for Weight Loss GlobeNewswire
Oct-04-19 12:48PM	A Look At Benzinga Pro's Most-Searched Tickers For October 4, 2019 Benzinga -8.67%
Oct-03-19 10:10AM	Obalon Shares Inflate As Weight Loss Balloon Maker Delivers Positive News Benzinga +9.50%
09:00AM	Obalon Announces Repayment of All Long-Term Debt and Regaining of Compliance with NASDAQ Listing Requirement GlobeNewswire
Sep-28-19 12:42PM	Obalon (OBLN) Alert: Johnson Fistel Announces Shareholder Class Action Against Obalon Therapeutics Survives Motion to Dismiss; Should Management be Held Accountable for Investors Losses? PR Newswire
Sep-03-19 09:00AM	Obalon Engages Helmuth T. Billy, MD as Medical Director for its First Company-Owned Weight Loss Treatment Center GlobeNewswire
Aug-05-19 09:00AM	Obalon Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference GlobeNewswire
Aug-02-19 08:48AM	Obalon Therapeutics Inc. Announces Pricing of $15,000,000 Public Offering GlobeNewswire -33.20%
Jul-26-19 04:00PM	Edited Transcript of OBLN earnings conference call or presentation 24-Jul-19 12:30pm GMT Thomson Reuters StreetEvents +21.72%
Jul-24-19 09:05AM	OBALON THERPTCS (OBLN) Reports Q2 Loss, Misses Revenue Estimates Zacks -40.41%
08:53AM	Obalon Announces Reverse Stock Split Effective Today GlobeNewswire
07:45AM	Obalon Announces Second Quarter 2019 Financial Results GlobeNewswire
Jul-23-19 08:30AM	Obalon Enters Into Commercial Lease for its First Company-Owned Retail Weight Loss Center GlobeNewswire +31.51%
Jul-22-19 09:00AM	Obalon Schedules Second Quarter 2019 Financial Results Conference Call for July 24, 2019 at 8:30 a.m. Eastern Time GlobeNewswire +20.66%
Jul-16-19 08:30AM	Obalon Obtains Two New U.S. Patents Covering Its Proprietary Intragastric Balloon System GlobeNewswire
Jul-10-19 08:30AM	Obalon Strengthens Balance Sheet By Raising Additional Capital And Reducing Debt GlobeNewswire +11.57%
Jun-24-19 08:30AM	Bariatric Medical Institute of Texas Presents Favorable Study Results for Obalon Balloon Administration Using Navigation Device and Touch Dispenser GlobeNewswire +26.34%
Jun-10-19 08:30AM	Obalon Appoints Bob MacDonald as Chief Retail Officer GlobeNewswire
Jun-04-19 11:42AM	Obalon Clinches First US Patent For Obesity Treatment Placement System Benzinga
08:30AM	Obalon Announces Issuance of First U.S. Patent Covering Its Proprietary Navigation System GlobeNewswire
Jun-03-19 08:57AM	Hottest Wall Street Stories: What's Up, What's Down Zacks
May-24-19 05:50PM	OBALON THERPTCS (OBLN) Stock Sinks As Market Gains: What You Should Know Zacks
12:50PM	A Look At Benzinga Pro's Most-Searched Tickers For May 24 Benzinga
May-23-19 10:00AM	Obalon Management Takes Advantage Of 200% Rally, Announces $3M Offering Benzinga -47.69%
08:30AM	Obalon Therapeutics, Inc. Prices $3,000,000 Registered Direct Offering GlobeNewswire
May-21-19 04:01PM	Expanded Clinical Data Set for the Obalon Balloon System Presented at DDW 2019 GlobeNewswire
May-17-19 05:50PM	OBALON THERPTCS (OBLN) Dips More Than Broader Markets: What You Should Know Zacks
04:01PM	Obalon Announces Receipt of Delisting Notification Letters from Nasdaq GlobeNewswire
May-02-19 10:33AM	Will OBALON THERPTCS (OBLN) Report Negative Q1 Earnings? What You Should Know Zacks
Apr-11-19 08:00AM	Obalon Engages Cowen to Explore Financial and Strategic Alternatives GlobeNewswire -7.43%
Apr-03-19 08:30AM	Obalon Announces Restructuring to Streamline Operations & Cash Use GlobeNewswire -61.87%
Mar-14-19 09:00AM	Obalon Announces Upcoming Conference Presentations GlobeNewswire
Feb-27-19 09:00AM	Obalon Announces First Commercial Use of Navigation and Touch Products for Obalon Balloon Administration GlobeNewswire -6.01%
Feb-26-19 02:15AM	Edited Transcript of OBLN earnings conference call or presentation 22-Feb-19 1:30pm GMT Thomson Reuters StreetEvents -6.54%
Feb-22-19 10:05AM	OBALON THERPTCS (OBLN) Reports Q4 Loss, Lags Revenue Estimates Zacks -10.09%
08:25AM	Obalon Announces First Commercial Shipment of its Navigation Balloon Placement System with Touch Inflation Dispenser GlobeNewswire
08:00AM	Obalon Announces Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
06:30AM	Obalon Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
Feb-21-19 09:38AM	How Many Insiders Bought Obalon Therapeutics, Inc. (NASDAQ:OBLN) Shares? Simply Wall St.
Feb-15-19 09:00AM	Obalon Schedules Fourth Quarter and Year End 2018 Financial Results Conference Call for February 22, 2019 at 8:30 a.m. Eastern Time GlobeNewswire
Jan-03-19 08:15AM	Obalon Announces Promotion of Amy VandenBerg to Chief Clinical & Regulatory Affairs Officer GlobeNewswire -15.65%
Jan-02-19 09:00AM	Obalon to Host Call to Provide Update on Commercial Strategy Post FDA Approval of the Obalon Navigation System GlobeNewswire +11.11%
08:45AM	Obalon Announces Promotion of Kelly Huang, Ph.D. To Chief Executive Officer GlobeNewswire
Dec-28-18 10:16AM	Small Cap Biotech Stocks on the Rise ACCESSWIRE -13.79%
07:29AM	The Daily Biotech Pulse: Opko Settles With SEC, Obalon Inks Financing Deals, Harpoon Files For IPO Benzinga
Dec-27-18 05:53PM	Obalon Therapeutics, Inc. Announces Two Agreements To Provide Up To $30 Million of Capital GlobeNewswire
Dec-21-18 10:45AM	These 4 Pharma Stocks Could Test December Highs ACCESSWIRE +61.59%
09:00AM	Obalon Announces FDA Approval of Obalon Navigation System GlobeNewswire
Dec-20-18 11:07AM	What You Must Know About Obalon Therapeutics, Inc.s (NASDAQ:OBLN) Financial Strength Simply Wall St.
Dec-19-18 12:38PM	Edited Transcript of OBLN earnings conference call or presentation 2-Aug-18 12:30pm GMT Thomson Reuters StreetEvents

Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallow able capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. As of February 27, 2020, it had three company-managed retail treatment centers in California. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience